NCT04294732

Brief Summary

In the orthopedic foot and ankle surgeries, the effects of postoperative popliteal nerve block applied for palliation of pain and local anesthetic agent in two different concentrations (0.166 and 0.250) which were used in popliteal nerve block procedure, will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 4, 2020

Completed
Last Updated

March 4, 2020

Status Verified

March 1, 2020

Enrollment Period

1 year

First QC Date

September 27, 2018

Last Update Submit

March 2, 2020

Conditions

Outcome Measures

Primary Outcomes (6)

  • pain relief activity of popliteal nerve block within thirty-six hours

    Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 12th hour. İf the numeric rating scale is above 3, it will be considered as pain.

    Postoperative 12th hour

  • pain relief activity of popliteal nerve block within thirty-six hours

    Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 24th hour. İf the numeric rating scale is above 3, it will be considered as pain.

    Postoperative 24th hour

  • pain relief activity of popliteal nerve block within thirty-six hours

    Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 36th hour. İf the numeric rating scale is above 3, it will be considered as pain.

    Postoperative 36th hour

  • pain relief activity of popliteal nerve block within three months

    Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at first months. İf the numeric rating scale is above 3, it will be considered as pain.

    Postoperative first month

  • pain relief activity of popliteal nerve block within three months

    Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at second months. İf the numeric rating scale is above 3, it will be considered as pain. İf pain persist over 1 month, ıt will be considered as chronic pain.

    Postoperative second month

  • pain relief activity of popliteal nerve block within three months

    Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at third months. İf the numeric rating scale is above 3, it will be considered as pain. İf pain persist over 1 month, ıt will be considered as chronic pain.

    Postoperative third month

Secondary Outcomes (6)

  • Investigate the pain relief activity of different concentrations within thirty-six hours

    Postoperative 12th hour.

  • Investigate the pain relief activity of different concentrations within thirty-six hours

    Postoperative 24th hour

  • Investigate the pain relief activity of different concentrations within thirty-six hours

    Postoperative 36th hour

  • Investigate the pain relief activity of different concentrations within three months

    Postoperative first month

  • Investigate the pain relief activity of different concentrations within three months

    Postoperative second month

  • +1 more secondary outcomes

Study Arms (3)

Only spinal anesthesia

PLACEBO COMPARATOR

Only spinal anesthesia without peripheral nerve block

Drug: Only spinal anesthesia without peripheral nerve block

high concentration

ACTIVE COMPARATOR

8 ml saline with 8 ml bupivacaine

Drug: Bupivacaine

low concentration

EXPERIMENTAL

8 ml bupivacaine with 16 ml of saline

Drug: Bupivacaine

Interventions

bupivacaine is a local anesthetic drug which is already using in surgical procedures. saline is isotonic solution of which has include %0,9 NACL.

Also known as: Saline
high concentrationlow concentration

Only spinal anesthesia without peripheral nerve block

Only spinal anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients undergoing orthopedic surgery on foot and ankle and who agreed to participate in the study

You may not qualify if:

  • Patients with sensitivity to local anesthetic
  • Patients who do not want to be included in the study
  • Preoperative mobilization and movement limitation
  • Patients who are not co-operate, cannot complete questionnaire forms and inquiry forms
  • Patients with skin infection at the injection site
  • Patients with diabetic neuropathy
  • Patients with bleeding disorder / Coagulopathy
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hazal Ezgi Çifci

Izmir, Eyalet/Yerleşke, 35500, Turkey (Türkiye)

Location

MeSH Terms

Interventions

BupivacaineSodium Chloride

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Spinal anesthesia will be performed in all three groups. During procedure 8 ml saline with 8 ml bupivacaine will be apply to the first group and 8 ml bupivacaine and 16 ml of saline will be apply to the second group. Only spinal anesthesia will be given to the third group without peripheral nerve block. The patients participating in the study will not be informed about which group they belong to, the person who makes the block will not prepare the drug and the person who makes the block, the patient and the nurse will not know which concentration drug applied to which patient.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study was designed to be prospective and randomized. Patients will be divided into 3 groups by simple randomization. The results of power analysis (G-power 3.1) revealed that a total of 60 patients were required to be included in the study. Because of that approximately 20 patients are planned for each group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator Hazal Ezgi Çifci

Study Record Dates

First Submitted

September 27, 2018

First Posted

March 4, 2020

Study Start

April 1, 2018

Primary Completion

April 1, 2019

Study Completion

January 1, 2020

Last Updated

March 4, 2020

Record last verified: 2020-03

Locations